Chemocentryx Enterprise Value Trend from 2010 to 2021

CCXI -  USA Stock  

USD 14.37  0.62  4.14%

Chemocentryx Enterprise Value is increasing over the last several years with slightly volatile swings. Enterprise Value is estimated to finish at about 4.6 B this year. During the period from 2010 to 2021 Chemocentryx Enterprise Value regressed destribution of quarterly values had coefficient of variationof 135.79 and r-squared of  0.56. Chemocentryx Interest Expense is most likely to increase significantly in the upcoming years. The last year's value of Interest Expense was reported at 2.64 Million. The current Selling General and Administrative Expense is estimated to increase to about 45.5 M, while Consolidated Income is projected to decrease to (56.8 M).

Search Historical Trends 

 
Refresh
Check Chemocentryx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemocentryx main balance sheet or income statement drivers, such as Gross Profit of 54.5 M, Interest Expense of 2.9 M or Operating Expenses of 98.9 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0482, PPandE Turnover of 4.86 or Receivables Turnover of 446. Chemocentryx financial statements analysis is a perfect complement when working with Chemocentryx Valuation or Volatility modules. It can also supplement various Chemocentryx Technical models. Continue to the analysis of Chemocentryx Correlation against competitors.

Chemocentryx Quarterly Enterprise Value

3.6 BillionShare

Chemocentryx Enterprise Value Breakdown

Showing smoothed Enterprise Value of Chemocentryx with missing and latest data points interpolated. Enterprise Value (or EV) is usually referred to as Chemocentryx theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Chemocentryx debt, but would also pocket its cash. Enterprise Value is more accurate representation of Chemocentryx value than its market capitalization because it takes into account all of Chemocentryx existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.Chemocentryx's Enterprise Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemocentryx's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 592.82 M10 Years Trend
Increasing
Slightly volatile
 Enterprise Value 
Share
      Timeline 

Chemocentryx Enterprise Value Regression Statistics

Arithmetic Mean 1,196,265,692
Geometric Mean 612,108,385
Coefficient Of Variation 135.79
Mean Deviation 1,269,004,781
Median 384,667,601
Standard Deviation 1,624,437,611
Range 4,400,143,230
R-Value 0.75
R-Squared 0.56
Significance 0.004936
Slope 338,046,369

Chemocentryx Enterprise Value History

2013226.4 M
2014275.2 M
2015342.9 M
2016339.9 M
2017272.2 M
2018541.8 M
20192.3 B
20204.3 B
20214.6 B

Other Fundumenentals of Chemocentryx

About Chemocentryx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chemocentryx income statement, its balance sheet, and the statement of cash flows. Chemocentryx investors use historical funamental indicators, such as Chemocentryx's Enterprise Value, to determine how well the company is positioned to perform in the future. Although Chemocentryx investors may use each financial statement separately, they are all related. The changes in Chemocentryx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chemocentryx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chemocentryx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chemocentryx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2021
Enterprise Value over EBIT(81.00) (83.13) 
Enterprise Value over EBITDA(85.85) (88.11) 
Enterprise Value4.3 B4.6 B
Tangible Asset Value518.9 M559.9 M
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Investors Sentiment

The influence of Chemocentryx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemocentryx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - CCXI

Chemocentryx Investor Sentiment

Most of Macroaxis users are currently bullish on Chemocentryx. What is your opinion about investing in Chemocentryx? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Chemocentryx

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemocentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemocentryx will appreciate offsetting losses from the drop in the long position's value.

Chemocentryx Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Chemocentryx and Dynavax Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to the analysis of Chemocentryx Correlation against competitors. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.